Continuation drug therapy for major depressive episodes: how long should it be maintained?
Authors:
- R F PrienRPR F Prien
- D J KupferDKD J Kupfer
- 1 January 1986
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 143 (1) , 18-23
Abstract
A major problem for the practitioner is the lack of satisfactory guidelines as to how long continuation drug treatment of depressive episodes must be maintained to ensure that the episode is over. This often leads to either premature withdrawal of the drug and subsequent relapse or unnecessarily prolonged treatment. Results from a collaborative project of the National Institute of Mental Health provide the first study-derived guidelines on the length of continuation therapy. Findings indicate that withdrawal of such therapy is safe only after the patient has been free of significant symptoms for 16 to 20 weeks and that focusing on mild as well as severe symptoms is critical in this decision.Keywords
This publication has 14 references indexed in Scilit:
- Slow wave sleep, shallow torpor and hibernation: Homologous states of diminished metabolism and body temperatureBiological Psychology, 1984
- Drug Therapy in the Prevention of Recurrences in Unipolar and Bipolar Affective DisordersArchives of General Psychiatry, 1984
- Long-Term Maintenance Pharmacotherapy in Recurrent and Chronic Affective Disorders1984
- A Farewell, a Greeting, and a Thought about Relapses in DepressionJournal of Clinical Psychopharmacology, 1983
- The Global Assessment ScaleArchives of General Psychiatry, 1976
- Prophylaxis of Affective DisordersArchives of General Psychiatry, 1976
- Lithium Carbonate and Imipramine in Prevention of Affective EpisodesArchives of General Psychiatry, 1973
- An evaluation of continuation therapy with tricyclic antidepressants in depressive illnessPsychological Medicine, 1973
- REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF-REPORT RATINGS OF HOSPITALIZED DEPRESSIVESJournal of Nervous & Mental Disease, 1969
- Imipramine in DepressionBMJ, 1959